• 1. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789
• 4. Acetyl protected thiol methacrylic polymers as effective ligands to keep quantum dots in luminescent standby mode?
  Marta Liras,Isabel Quijada-Garrido,Marta Palacios-Cuesta,Sonia Mu?oz-Durieux,Olga García Polym. Chem., 2014,5, 433-442
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Professional Introduction to N-Cbz-D-methionine (CAS No. 28862-80-8)

N-Cbz-D-methionine, chemically known by its CAS number 28862-80-8, is a significant compound in the field of pharmaceutical chemistry and biochemistry. This protected derivative of D-methionine plays a crucial role in the synthesis of peptides and proteins, particularly in the protection of methionine residues during peptide coupling reactions. The N-carboxybenzyloxy (Cbz) group is a widely used protecting group in organic synthesis, ensuring the stability and selectivity of the methionine side chain during various chemical modifications.

The utility of N-Cbz-D-methionine extends beyond its role as a protecting group. D-methionine, being an enantiomer of L-methionine, has unique biological properties that make it valuable in certain therapeutic applications. For instance, studies have shown that D-methionine exhibits different metabolic pathways compared to its L-isomer, which could be exploited in the development of novel drugs targeting specific enzymatic pathways. The Cbz protection allows researchers to manipulate these pathways without unintended side reactions, making N-Cbz-D-methionine an indispensable tool in medicinal chemistry.

In recent years, there has been growing interest in the use of protected amino acids like N-Cbz-D-methionine in the development of peptide-based therapeutics. Peptides have gained prominence due to their high specificity and lower immunogenicity compared to small molecule drugs. The ability to precisely control the structure and function of peptides through protecting groups has been a key factor in their successful development. For example, N-Cbz-D-methionine has been employed in the synthesis of peptidomimetics that mimic natural peptide sequences but with enhanced stability and bioavailability.

The latest research in this area highlights the potential of N-Cbz-D-methionine in addressing neurological disorders. A study published in the Journal of Medicinal Chemistry demonstrated that peptidomimetics incorporating D-methionine residues exhibit improved blood-brain barrier penetration compared to their L-isomer counterparts. This finding is particularly relevant for treating neurodegenerative diseases where drug delivery across the blood-brain barrier is a major challenge. The use of N-Cbz-D-methionine as a building block in these peptidomimetics underscores its importance in advancing therapeutic strategies for neurological conditions.

Another area where N-Cbz-D-methionine has shown promise is in the field of cancer research. Cancer cells often exhibit altered metabolic pathways that can be exploited for therapeutic gain. D-methionine has been identified as a key player in cancer cell metabolism, particularly in terms of methylation processes that are essential for DNA synthesis and repair. By incorporating N-Cbz-D-methionine into targeted therapies, researchers aim to disrupt these metabolic pathways selectively, thereby inhibiting cancer cell growth while minimizing side effects on healthy cells.

The synthesis and application of N-Cbz-D-methionine also benefit from advancements in synthetic methodologies. Modern techniques such as solid-phase peptide synthesis (SPPS) have made it possible to incorporate protected amino acids like N-Cbz-D-methionine with high efficiency and precision. This has enabled the rapid design and production of complex peptide drugs that were previously difficult or impossible to synthesize. The versatility of N-Cbz-D-methionine as a building block continues to drive innovation in peptide chemistry and drug development.

In conclusion, N-Cbz-D-methionine (CAS No. 28862-80-8) is a versatile and essential compound in pharmaceutical chemistry and biochemistry. Its role as a protecting group for D-methionine residues has made it indispensable in peptide synthesis, while its unique biological properties have opened new avenues for therapeutic applications. Recent research highlights its potential in addressing neurological disorders and cancer, demonstrating its significance in advancing drug development efforts worldwide.

• 56762-93-7(Z-L-Methionine methyl ester)
• 1138-80-3(Z-Glycine)
• 1148-11-4(Carbobenzoxyproline)
• 4434-61-1(N-Carbobenzoxy-DL-methionine)
• 405-39-0(Z-Lys(Z)-OH)
• 1115-47-5(N-Acetyl-DL-methionine)
• 1145-80-8(N-Carboxybenzyl-L-serine)
• 1152-61-0(Z-Asp-OH)
• 1152-62-1(Z-Met-OH)
• 1149-26-4(N-Cbz-L-valine)